At BIO Digital more than 5,000 participants from 55 countries come together for a One-on-One Partnering, education and networking with professionals from life science and pharmaceutical industry…
News
Communication is key to success, this is also true for science
Stay updated with the most recent developments and activities at Taros by reading our news articles. Our scientists and business development are regularly attending relevant trade fairs, congresses, conferences, symposiums and events across the globe. Follow our events news and contact us to pre-arrange a meeting. Customer confidentiality and the protection of their intellectual property which we create on their behalf is always of most importance. However, we are always happy to co-author and contribute to scientific publications that give evidence of a successful collaboration.
Read more
The Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates…
LOPEC is the leading trade fair and the most important conference for the printed electronics industry. It is the leading global platform for the industry and provides guidance in every aspect of the industry, from application to research…
The BIO-Europe® Spring takes place annually in changing cities and is an international forum for promoting business development between pharmaceutical, financial and biotechnology companies…
The 34th electronic displays Conference (edC) will act again as a major forum for the presentation of innovative ideas, approaches, developments and research projects in the area of today’s and future display business. From 26 to 27 February 2020, developers, scientists and users of electronic displays will…
A consortium comprising Grünenthal, Taros Chemicals and three research groups from the Institute for Neurosciences and Medicine (INM) of the Research Centre Jülich employed positron emission tomography (PET) as imaging method to investigate the interaction of a single drug with two specific targets…
Cardiovascular diseases are still one of the most frequent causes of death. Since the heart muscle cannot regenerate itself, the tissue is usually remodeled leading to impaired heart function in the long term. Many patients who have survived a heart attack suffer from cardiac insufficiency years later…
Angew Chem Int Ed Engl. 2020: Christian Ottmann, Madita Wolter, Dario Valenti, Peter J Cossar, Laura M. Levy, Stanimira Hristeva, Thorsten Genski, Torsten Hoffmann, Luc Brunsveld, Dimitrios Tzalis,
Taros EVP Youri R. Mesmoudi was interviewed in the current Issue of CHEManager´s Section Chemistry & Life Sciences on “From Idea to Product – the principle of an extended workbench accelerates innovation in chemistry”
Due to current situation with the spread of the Sars-CoV-2 (“Coronavirus”) we want to share with you the latest information on how Taros Chemicals have prepared for both, the protection of our employees and partners’ health and the uninterrupted continuation of our chemistry and discovery services to our clients…
The ECP is the european business speed dating platform for the chemical industry and its processing and user sectors like consumer goods, cosmetics, plastics and adhesives, paints, coatings and varnishes, health, nutrition, flavors, fragrances and analytics…
Drug Discovery Strategic Summit highlights the advances in current and emerging hot targets and technologies, as well as target validation strategies for the discovery and development from biologics to small molecules. DDSS is custom designed to provide an exceptional platform to unfold…
SelectBIO Organ-on-a-Chip, Tissue-on-a-Chip & Organoids Europe 2020 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of “assembled cells” have…
This edition will continue the tradition established for these symposia of covering advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the CNS, heart disease, fibrotic diseases and cancer…
Ahead of Oxford Global’s R&D Series Drug Discovery Virtual on 29-30 July 2020 in Berlin, Germany, Oxford Global spoke to Torsten Hoffmann of Taros Chemicals about his work in Pharmaceutical R&D and the opportunities and challenges in Drug Discovery…
I3-STM dealt with a new, tailor-made immunotherapeutic approach using small antibody mimetics synthesized for the therapy of triple-negative breast cancer (TNBC), which is still insufficiently treated with the classic methods. These drugs consist of components that stimulate the immune system and…
Looks interesting?
As a leading contract research organization in discovery chemistry and custom synthesis, Taros provides comprehensive solutions to meet our clients’ needs from diverse branches and applications
Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
